Τρίτη 26 Σεπτεμβρίου 2017

Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228)

Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228)

British Journal of Cancer 117, 965 (26 September 2017). doi:10.1038/bjc.2017.278

Authors: Francis Lévi, Abdoulaye Karaboué, Raphaël Saffroy, Christophe Desterke, Valerie Boige, Denis Smith, Mohamed Hebbar, Pasquale Innominato, Julien Taieb, Carlos Carvalho, Rosine Guimbaud, Christian Focan, Mohamed Bouchahda, René Adam, Michel Ducreux, Gérard Milano & Antoinette Lemoine



from Cancer via ola Kala on Inoreader http://ift.tt/2vHkHYv
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου